Glow-in-the-Dark dye could help surgeons spot hidden breast cancer

NCT ID NCT05900986

First seen Oct 31, 2025 · Last updated May 18, 2026 · Updated 29 times

Summary

This study tests a new dye called LS301-IT that makes cancer cells glow during breast cancer surgery. About 100 women with early-stage breast cancer or DCIS will receive the dye before their partial mastectomy. The goal is to see if the dye is safe and helps surgeons remove all cancer while sparing healthy tissue.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Integro Theranostics Clinical Research Site #8

    Winston-Salem, North Carolina, 27103, United States

  • Integro Theranostics Research Site #10

    Cleveland, Ohio, 44195, United States

  • Integro Theranostics Research Site #12

    Washington D.C., District of Columbia, 20059, United States

  • Integro Theranostics Research Site #2

    Scottsdale, Arizona, 85260, United States

  • Integro Theranostics Research Site #3

    Dallas, Texas, 75290, United States

  • Integro Theranostics Research Site #5

    Philadelphia, Pennsylvania, 19107, United States

  • Integro Theranostics Research Site #6

    The Bronx, New York, 10461, United States

  • Integro Theranostics Research Site #9

    Weston, Florida, 33331, United States

  • Integro Theronostics Research Site #1

    Houston, Texas, 77030, United States

Conditions

Explore the condition pages connected to this study.